Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655549 · ClinicalTrials.gov registry record · Phase 1
A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects
A Phase 1 study, sponsored by Pfenex.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT02655549: Completed Phase 1 study, sponsored by Pfenex.
NCT02655549 is a Phase 1 study that has completed, run by Pfenex. The registered enrollment target is 54 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02655549, a Phase 1 study, has completed, sponsored by Pfenex.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The trial investigates Px563L and RPA563, two formulations of a novel anthrax vaccine.
Interventions
- BIOLOGICAL Px563L, RPA563, or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-06 |
| Phase | Phase 1 |
What the finished NCT02655549 record still lists
NCT02655549 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 1 intervention - of which Px563L, RPA563, or placebo is the first listed.
NCT02655549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02655549 about?
NCT02655549 is a clinical study titled "A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects". The trial investigates Px563L and RPA563, two formulations of a novel anthrax vaccine.
What is the current status of trial NCT02655549?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2015-12. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02655549?
The interventions under investigation include: Px563L, RPA563, or placebo (BIOLOGICAL).
Who is sponsoring clinical trial NCT02655549?
This trial is sponsored by Pfenex, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02655549's enrollment target sits among peer trials
54 931st of 2000 higher than 1,053 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia